Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine. (July 2022)

Record Type:: Journal Article
Title:: Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine. (July 2022)
Main Title:: Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
Authors:: Mechtler, Laszlo
Saikali, Nicolas
McVige, Jennifer
Hughes, Olivia
Traut, Alexandra
Adams, Aubrey
Abstract:
Is Part Of:: Toxicon. Volume 214(2022)Supplement 1
Journal:: Toxicon
Issue:: Volume 214(2022)Supplement 1
Issue Display:: Volume 214, Issue 1 (2022)
Year:: 2022
Volume:: 214
Issue:: 1
Issue Sort Value:: 2022-0214-0001-0000
Page Start:: S40
Page End:: S41
Publication Date:: 2022-07
Subjects:: Toxins -- Periodicals
Venom -- Periodicals
615.9
Journal URLs:: http://www.sciencedirect.com/science/journal/00410101 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.toxicon.2021.11.088 ↗
Languages:: English
ISSNs:: 0041-0101
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8873.050000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 22757.xml